Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05836870 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tele-PancFit: A Multi-site Trial of Video-based Strengthening Exercise Prehabilitation for Patients With Resectable Pancreatic Cancer

StatusActive, Not Recruiting
PhasePhase 3
Started2023-07-18
View on ClinicalTrials.gov ↗

Amendment history

2026-08-10
Study Status v8
Re-verified, no change to tracked fields
2026-02-26
Recruiting→Active, Not Recruiting Study Status, Study Design, Contacts/Locations v7
Trial statusRecruiting→Active, Not Recruiting
Enrollment targetestimated 120→confirmed 58
Study sitesdetails revised at 1 of 1 site
2025-08-12
Study Status, Oversight, Contacts/Locations v6
Study sitescontacts updated at 1 of 1 site
2025-01-28
Study Status, Oversight, Contacts/Locations v5
Study sitescontacts updated at 1 of 1 site
2024-06-24
Study Status, Eligibility v4
Eligibility criteria+2 characters
[...] arcinoma, resectable/borderline resectable (T1-3, N0-2, M0) ScheduledRecommended to receive 2-6 months of neoadjuvant chemotherapy followed [...]
Show 3 earlier versions
2024-06-06
Study Status v3
Re-verified, no change to tracked fields
2023-12-01
Study Status, Outcome Measures, Eligibility v2
Eligibility criteria+139 characters
[...] ed and dated informed consent form Biopsy-proven pancreatic ductal adenocarcinoma (PDAC), resectable/borderline resectable (T1-3, N0-2, M0) Scheduled to receive 2-46 months of neoadjuvant chemotherapy followed by surgical resection including participants who have not yet received chemotherapy and participants who have already received their first cycle of chemotherapy. Willingness to adhere to the Tele-PancFit study interventio [...] the study, exercise program, and willing to participate Home or community access to wireless internet (Wi-Fi) and agreement to engage [...]
Primary endpoints1 entry, revised
FunctionalSafety Assessmentand ofadverse Cancer Therapy-Hepatobiliaryevents (FACT-HepAEs) questionnaires
2023-07-18
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2023-10-31→confirmed 2023-07-18
Study sitesdetails revised at 1 of 1 site
2023-04-20
Original filing
To learn if a supervised exercise program during chemotherapy treatments can help to improve outcomes in patients who have been diagnosed with pancreatic cancer
Trial Details
NCT Number NCT05836870
Lead Sponsor M.D. Anderson Cancer Center
Conditions Pancreatic Cancer
Enrollment 58 participants
Start Date 2023-07-18
Primary Completion 2030-12-31 (estimated)
Study Completion 2032-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-12